The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

Completion of preclinical data package for RAD 402

by admin December 10, 2024
December 10, 2024
Completion of preclinical data package for RAD 402

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Lundin Mining to Divest Neves-Corvo and Zinkgruvan Operations for US$1.52 Billion
next post
Capital Raising and QSM Completion Update

Related Posts

Forward Water Technologies Corp. Announces Filing of its...

August 29, 2024

Tavi Costa: Gold’s Next Catalyst, Silver’s Path to...

August 26, 2025

Pharma Market Forecast: Top Trends for Pharma in...

January 14, 2025

What is Synthetic Graphite?

January 31, 2025

5 Key Announcements from Google’s I/O Event

May 17, 2024

Letter from the CEO: Unlocking the True Value...

March 27, 2025

Silver Crown Royalties Announces Annual General Meeting Results

June 25, 2025

Peter Krauth: Silver Market “Very Tight,” Watch This...

March 6, 2025

JZR Gold Inc. Closes Non-Brokered Private Placement Offering...

March 5, 2025

Anglo American Rejects BHP’s “Undervalued” US$38.8 Billion Bid

April 27, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,579)
    • Investing (4,814)
    • Politics (6,343)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved